Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-Cancer landscape of protein activities identifies drivers of signalling dysregulation and patient survival. | Mol Syst Biol | 2023 | 36688815 | PubTator, text mining | PubMed |
| Endo-Lysosomal and Autophagy Pathway and Ubiquitin-Proteasome System in Mood Disorders: A Review Article. | Neuropsychiatr Dis Treat | 2023 | 36684613 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
| Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer. | Molecules | 2023 | 36677797 | PubTator, text mining | PubMed |
| Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma. | Elife | 2023 | 36656749 | PubTator, text mining | PubMed |
| Characterizing crosstalk in epigenetic signaling to understand disease physiology. | Biochem J | 2023 | 36630129 | PubTator, text mining | PubMed |
| Psoralea corylifolia L.: a comprehensive review of its botany, traditional uses, phytochemistry, pharmacology, toxicology, quality control and pharmacokinetics. | Chin Med | 2023 | 36627680 | PubTator, text mining | PubMed |
| Dynamic regulation of RAS and RAS signaling. | Biochem J | 2023 | 36607281 | PubTator, text mining | PubMed |
| Common Key Genes in Differentiating Parathyroid Adenoma From Thyroid Adenoma. | Horm Metab Res | 2023 | 36599456 | PubTator, text mining | PubMed |
| Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G1/S cell cycle transition. | Biochem Biophys Res Commun | 2023 | 36566564 | PubTator, text mining | PubMed |
| Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. | Cancer Cell | 2023 | 36563681 | PubTator, text mining | PubMed |
| Preferential formation of human heteromeric SK2:SK3 channels limits homomeric SK channel assembly and function. | J Biol Chem | 2023 | 36502918 | PubTator, text mining | PubMed |
| Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier. | Antiviral Res | 2023 | 36423831 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease. | Mol Cell Proteomics | 2023 | 36423813 | PubTator, text mining | PubMed |
| Transcriptomic analysis of the liver in aged laying hens with different eggshell strength. | Poult Sci | 2023 | 36343436 | PubTator, text mining | PubMed |
| Missense MED12 variants in 22 males with intellectual disability: From nonspecific symptoms to complete syndromes. | Am J Med Genet A | 2023 | 36271811 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| The role of RAS oncogenes in controlling epithelial mechanics. | Trends Cell Biol | 2023 | 36175301 | PubTator, text mining | PubMed |
| Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices. | Mol Divers | 2023 | 36057867 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=12